These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 39000060)
1. Exercise to Counteract Alzheimer's Disease: What Do Fluid Biomarkers Say? Bonanni R; Cariati I; Cifelli P; Frank C; Annino G; Tancredi V; D'Arcangelo G Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000060 [TBL] [Abstract][Full Text] [Related]
2. β-amyloid and tau drive early Alzheimer's disease decline while glucose hypometabolism drives late decline. Hammond TC; Xing X; Wang C; Ma D; Nho K; Crane PK; Elahi F; Ziegler DA; Liang G; Cheng Q; Yanckello LM; Jacobs N; Lin AL Commun Biol; 2020 Jul; 3(1):352. PubMed ID: 32632135 [TBL] [Abstract][Full Text] [Related]
3. Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction. Compta Y; Revesz T J Parkinsons Dis; 2021; 11(1):107-121. PubMed ID: 33325398 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology. Gordon BA; Blazey T; Su Y; Fagan AM; Holtzman DM; Morris JC; Benzinger TL JAMA Neurol; 2016 Oct; 73(10):1192-1200. PubMed ID: 27548756 [TBL] [Abstract][Full Text] [Related]
10. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies. Zetterberg H; Bendlin BB Mol Psychiatry; 2021 Jan; 26(1):296-308. PubMed ID: 32251378 [TBL] [Abstract][Full Text] [Related]
12. Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer's Disease? McLimans KE; Clark BE; Plagman A; Pappas C; Klinedinst B; Anatharam V; Kanthasamy A; Willette AA Antioxid Redox Signal; 2019 Sep; 31(8):572-578. PubMed ID: 31088292 [TBL] [Abstract][Full Text] [Related]
13. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease. Prvulovic D; Hampel H Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022 [TBL] [Abstract][Full Text] [Related]
14. Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease. Cohen AD; Landau SM; Snitz BE; Klunk WE; Blennow K; Zetterberg H Mol Cell Neurosci; 2019 Jun; 97():3-17. PubMed ID: 30537535 [TBL] [Abstract][Full Text] [Related]
17. High Levels of Piccarducci R; Pietrobono D; Pellegrini C; Daniele S; Fornai M; Antonioli L; Trincavelli ML; Blandizzi C; Martini C Oxid Med Cell Longev; 2019; 2019():5030475. PubMed ID: 31281579 [TBL] [Abstract][Full Text] [Related]
18. The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention. Tolar M; Hey JA; Power A; Abushakra S Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473975 [TBL] [Abstract][Full Text] [Related]
19. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
20. Exploring the relationship between physical activity, beta-amyloid and tau: A narrative review. Brown BM; Peiffer J; Rainey-Smith SR Ageing Res Rev; 2019 Mar; 50():9-18. PubMed ID: 30615936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]